Clinical Trial

Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this clinical study is to find out how NNC0487-0111 affects, how the body uses insulin (a hormone that helps the body control blood sugar) and how well the pancreas works in people living with type 2 diabetes. There are 2 study treatments. Participants will get either NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-25
Trial Details
NCT Number NCT07535307
Lead Sponsor Novo Nordisk A/S
Conditions Diabetes Mellitus
Enrollment 80 participants
Start Date 2026-04-10
Primary Completion 2027-11-11 (estimated)
Study Completion 2027-12-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-24